Navigo Proteins GmbH

Germany


 
Total IP 109
Total IP Rank # 12,131
IP Activity Score 2.7/5.0    63
IP Activity Rank # 11,480
Dominant Nice Class Scientific, technological and in...

Patents

Trademarks

29 6
23 0
32 5
14
 
Last Patent 2025 - Novel serum albumin-binding fusi...
First Patent 2003 - Mixture of at least two fusion p...
Last Trademark 2023 - HEAD
First Trademark 2012 - Affilin

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Novel serum albumin-binding fusion proteins. The invention relates to fusion proteins that compri...
2023 Invention New ligands for affinity chromatography. The present invention relates to novel ligands for affin...
Invention Novel proteins with high binding affinity to programmed death ligand 1 (pd-l1)
Invention Novel proteins with high binding affinity to programmed death ligand 1 (pd-l1). The present inven...
Invention Fusion proteins with half life extending domains
Invention Fusion proteins with half life extending domains. The invention relates to a fusion protein that ...
G/S Scientific, technological, and industrial research services all in the field of half-life modifyi...
Invention High affinity purification of ferritin. The present invention relates to novel proteins that spec...
2022 Invention Specific binding molecules for fibroblast activation protein (fap). The present invention relates...
Invention Specific baculovirus major envelope glycoprotein gp64 binding proteins. gp64 is the major envelo...
Invention Specific baculovirus major envelope glycoprotein gp64 binding proteins. gp64 is the major envelop...
Invention Affinity ligands for the purification and detection of ubiquitin muteins. The present invention ...
Invention Affinity ligands for the purification and detection of ubiquitin muteins. The present invention r...
G/S Biological, diagnostic, therapeutic, biochemical substances, active agents, and/or compositions f...
Invention Novel human programmed death ligand 1 (pd-l1) specific binding molecules. The present invention ...
Invention Novel human programmed death ligand 1 (pd-l1) specific binding molecules. The present invention r...
G/S Chemical, biological, analytical, and/or chromatographic substances, active agents, and/or compos...
2021 Invention Binding proteins for complement factor h (cfh). The present invention relates to novel proteins ...
Invention Binding protein for complement factor h (cfh). The present invention relates to novel proteins th...
Invention New type ii collagen binding proteins. The present invention relates to new type II collagen alp...
Invention Novel type ii collagen binding proteins. The present invention relates to new type II collagen al...
Invention Fusion proteins with specifity for type ii collagen and vegf-a for the treatment of eye diseases....
Invention Serum stable binding proteins for human her2 for theranostic applications. The present disclosur...
Invention Serum stable binding proteins for human her2 for theranostic applications. The present disclosure...
Invention Immunoglobulin binding proteins for affinity purification. The present invention relates to immun...
Invention Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus ...
Invention Novel immunoglobulin binding polypeptides. The present invention relates to novel engineered art...
Invention Novel immunoglobulin binding polypeptides. The present invention relates to novel engineered arti...
Invention Affinity ligand for the soluble part of fibroblast growth factor receptor 3 (sfgfr3). The presen...
Invention Affinity ligand for the soluble part of fibroblast growth factor receptor 3 (sfgfr3). The present...
2020 Invention Binding proteins for the enzyme acid alpha glucosidase (gaa) and uses thereof. The present invent...
Invention Novel psma specific binding proteins for cancer diagnosis and treatment. The present invention r...
Invention Novel psma specific binding proteins for cancer diagnosis and treatment. The present invention re...
Invention Immunoglobulin binding proteins for affinity purification. The present invention relates to immu...
2019 Invention Novel folr1 specific binding proteins for cancer diagnosis and treatment. The present invention ...
Invention Novel folr1 specific binding proteins for cancer diagnosis and treatment. The present invention r...
Invention Novel triple-helical polypeptides lacking binding affinity for the fc domain of immunoglobulin an...
G/S Chemical, biological, analytical and/or chromatographic substances, active ingredients and/or com...
2018 G/S Diagnostic, therapeutic, analytical, biological, chemical, biochemical substances, active agents...
G/S Diagnostic, therapeutic, analytical, biological, chemical, biochemical substances, active agents,...
Invention Fusion proteins with specificity for ed-b and long serum half-life for diagnosis or treatment of ...
G/S Chemicals, biological, analytical, and/or chromatographic preparations, active agents, and/or co...
G/S Chemicals, biological, analytical, and chromatographic preparations, active agents, and compositi...
G/S Chemicals, biological, analytical, and/or chromatographic preparations, active agents, and/or com...
G/S Chemische, biologische, analytische, und/oder chromatographische Erzeugnisse, Wirkstoffe, und/ode...
2017 G/S Chemical, biological, analytical, and/or chromatographic substances, active agents, and/or compo...
2012 G/S Chemicals used in industry and science,In particular comprising antibody-like proteins or parts t...